NCT07302282 The Effectiveness of Pain Neuroscience Education for Patients With Carpal Tunnel Syndrome
| NCT ID | NCT07302282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Karamanoğlu Mehmetbey University |
| Condition | Carpal Tunnel Syndrome (CTS) |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2025-12-29 |
| Primary Completion | 2026-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2025-12-29 with a primary completion date of 2026-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to investigate the effects of Pain Neuroscience Education applied in the treatment of mild and moderate carpal tunnel syndrome (CTS). The main question it aims to answer is: Does PNE have a therapeutic effect on carpal tunnel syndrome in clinical and ultrasonographic terms? Researchers will compare whether PNE creates a synergistic effect alongside home based exercise programs and splint application in mild to moderate CTS, and will objectively demonstrate potential benefits such as relief from pain and numbness.
Eligibility Criteria
Inclusion Criteria: * Being 18 years of age or older * Having a diagnosis of mild or moderate CTS confirmed by ENMG * Having complaints of pain and numbness in the first three fingers of the hand for at least 3 months Exclusion Criteria: * Presence of severe CTS findings on electrophysiological examination * Presence of metabolic diseases such as uncontrolled diabetes and hypothyroidism * Presence of inflammatory rheumatic disease (e.g., rheumatoid arthritis) * Presence of other neuromuscular diseases affecting the hand and wrist (Polyneuropathy, Cervical radiculopathy, peripheral nerve damage, Brachial plexus damage, other entrapment neuropathies, etc.) * History of hand and wrist trauma * History of neck and wrist surgery * History of steroid injection into the carpal tunnel within the last 3 months * History of physical therapy application to wrist within the last 3 months * Deformity preventing the use of a splint on the wrist * Previous participation in a program for the psychological management of chronic pain * Cognitive dysfunction preventing cooperation with tests
Contact & Investigator
Mahmut Talha Susam, MD
STUDY CHAIR
Karamanoglu Mehmetbey University Physical Medicine and Rehabilitation
Frequently Asked Questions
Who can join the NCT07302282 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Carpal Tunnel Syndrome (CTS). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07302282 currently recruiting?
Yes, NCT07302282 is actively recruiting participants. Contact the research team at mahmuttalhasusam@kmu.edu.tr for enrollment information.
Where is the NCT07302282 trial being conducted?
This trial is being conducted at Karaman, Turkey (Türkiye).
Who is sponsoring the NCT07302282 clinical trial?
NCT07302282 is sponsored by Karamanoğlu Mehmetbey University. The principal investigator is Mahmut Talha Susam, MD at Karamanoglu Mehmetbey University Physical Medicine and Rehabilitation. The trial plans to enroll 48 participants.